The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
An at-home, mail-in, finger-stick blood test detected Alzheimer’s-related biomarkers associated with cognitive performance in ...
A newly published study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits ...
In a study published in Neurochemistry International, researchers found that arginine reduced the buildup of toxic amyloid β ...
A novel approach using a lysosomal enzyme to prevent and reverse amyloid accumulation inside as well as outside neurons, with greater potency, delivered in a one-time gene therapy ...
New blood tests measuring p-tau217 levels show promise for predicting Alzheimer's risk years before symptoms appear, though ...
5h
Alzheimer’s Treatment Drug Launched In India At Nearly ₹1 Lakh Per Dose, Here's All You Need To Know
Priced at Rs 91,688 for a 350 mg vial, the prescription-only intravenous therapy is to be administered once a month for up to ...
Doctors and patients are gaining an edge in the fight against Alzheimer’s disease by catching early warning signs with new screening methods.
The retraction came from Neurobiology of Aging, which removed a 2011 paper claiming to show that a version of a protein ...
A study from researchers at Loma Linda University in California suggests that eating eggs — fairly frequently — could be ...
A new study offers fresh insight into Alzheimer's disease by looking beyond the brain and focusing on metabolic health, ...
Once-monthly drug aims to slow cognitive decline in patients with early-stage Alzheimer’s disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results